Abstract
Tungiasis is a neglected tropical skin disease caused by the sand flea, Tunga penetrans which penetrates the skin causing considerable pain and itching. In this cross-sectional study we aimed to assess its impact on the quality of life of school children in Kenya.
School pupils (198) aged 8-14 years with tungiasis were randomly selected and interviewed using a tungiasis-specific quality of life instrument (TLQI). The caregivers of each infected pupil and 199 randomly selected caregivers of uninfected pupils were interviewed using the proxy KIDscreen52® to assess their child’s general health-related quality of life (HR-QoL). Generalized linear models were used to assess associations between quality-of-life variables, children’s tungiasis status and other covariables.
Among infected children, 62.4% had TLQI scores reflecting a moderate to very high impact, with no significant difference between mild and severe cases. Severe cases had a lower proxy-HR-QoL than uninfected pupils (β −21.15, 95% CI −39.63 − −2.68, p=0.025), but this was not significant in multivariable models. For the first time, this study demonstrated for children whose caregivers were depressed, tungiasis had a higher impact on their quality of life (TLQI adjusted β 0.28, 95% CI 0.08−0.49, p=0.006) and had a lower general HR-QoL (adjusted β −40.34, 95%CI −55.91− −24.76, p<0.001). Conversely, if their caregiver showed them affection, tungiasis had a lower impact on their quality of life (TLQI, adjusted β −0.45, 95% CI −0.70− −0.20, p<0.001).
Further studies are needed to investigate the interaction of tungiasis with parenting styles, the mental health of children and their caregivers and their effect on children’s well-being.
Plain English Summary Tungiasis is an extremely neglected tropical skin disease which causes immense suffering among children in resource poor communities in many tropical countries. A good quality of life is considered a Right of all people and is consequently used as the most important outcome of treatment programs. The impact on quality of life by tungiasis has only been investigated in very few studies, but evidence of impact is needed to monitor interventions. Here we assessed the impact of the disease on the quality of life of school pupils using a disease-specific instrument with children and a general health-related instrument with their caregivers. The study demonstrated the considerable impact tungiasis has on the quality of life of school-age children. Tungiasis affected children’s ability to sleep and caused feelings of sadness and shame. Tungiasis had a greater impact on children whose caregivers were depressed, and they had a lower general health-related quality of life. Conversely, tungiasis had a lower impact on quality of life for children whose caregivers showed them affection. Further research is needed to investigate the interaction of tungiasis with parenting styles and the mental health of children and their caregivers and their effect on children’s well-being.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://doi.org/10.7910/DVN/TKXWRF
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the KEMRI Scientific and Ethics Review Committee approval number non-KEMRI 644. Permission to conduct the study was also obtained from the county and sub-county Health Management Teams and the Department of Education. Informed consent was obtained from the school Head Teachers and PTA chairperson. Caregivers of the pupils selected for interviews gave informed consent for their own involvement as well as for their child, all ages enrolled. In addition, pupils aged 12 to 14 years themselves gave signed informed assent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets supporting the conclusions of this article are available on the KEMRI-Wellcome Trust Research Programme (KWTRP) Research Data Repository at Harvard Dataverse through the following link: https://doi.org/10.7910/DVN/TKXWRF
